atai Life Sciences to Participate in Upcoming June Healthcare Conferences

Rhea-AI Summary

atai Life Sciences (Nasdaq: ATAI), a biopharmaceutical company focused on mental health treatments, will participate in key healthcare conferences this June. The BIO International Conference will feature a company presentation on June 16 from 2:45 PM to 3:15 PM ET. Following this, the H.C. Wainwright 1st Annual Mental Health Conference is scheduled for June 27 at 12:00 PM ET. Both events aim to highlight atai's innovative approaches to mental health disorders. Archived webcasts will be available on atai's website for further insights.

NEW YORK and BERLIN, June 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming healthcare conferences in June:

• BIO International Conference
  

                        Format: Company Presentation – In Person
                        Date and Time: Thursday, June 16^th, 2:45 p.m. ET – 3:15 p.m. ET
                        Conference Link: URL

• H.C. Wainwright 1^st Annual Mental Health Conference
  

                        Format: Company Presentation – Hybrid
                        Date and Time: Monday, June 27^th, 12:00 p.m. ET – 12:30 p.m. ET
                        Conference Link: URL

The presentation and archived webcast will also be accessible in the Events section of atai’s website.

About atai Life Sciences
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.

atai's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and non-psychedelic compounds with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies, seeking to effectively treat and ultimately heal mental health disorders.

atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Forward-Looking Statements
These presentations may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in these presentations that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the important factors described in the section titled “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”), as updated by our subsequent filings with the SEC, as such factors may be updated from time to time in atai's other filings with the SEC. atai disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.

Contact Information

Investor Contact:
Greg Weaver,
Chief Financial Officer, atai Life Sciences
Email: IR@atai.life

Media Contact:
Allan Malievsky,
Senior Director, External Affairs
Email: allan@atai.life

FAQ

When is atai Life Sciences' presentation at the BIO International Conference?

atai Life Sciences will present at the BIO International Conference on June 16, 2022, from 2:45 PM to 3:15 PM ET.

What is the format of the H.C. Wainwright 1st Annual Mental Health Conference?

The H.C. Wainwright 1st Annual Mental Health Conference will be a hybrid event featuring a company presentation by atai Life Sciences on June 27, 2022, from 12:00 PM to 12:30 PM ET.

Where can I find archived webcasts of atai Life Sciences' presentations?

Archived webcasts of atai Life Sciences' presentations will be available on their official website under the Events section.

What is the focus of atai Life Sciences?

atai Life Sciences focuses on transforming the treatment of mental health disorders through innovative therapeutics and therapies.

What is the significance of the June conferences for ATAI?

The June conferences are significant for ATAI as they provide a platform to present their advancements in mental health treatment and to engage with industry stakeholders.